Author
Listed:
- Koenecke, Allison
(Institute for Computational and Mathematical Engineering, Stanford U)
- Powell, Michael
(Johns Hopkins U)
- Xiong, Ruoxuan
(Stanford U)
- Shen, Zhu
(Stanford U)
- Fischer, Nicole
(Johns Hopkins U School of Medicine)
- Huq, Sakibul
(Johns Hopkins U School of Medicine)
- Khalafallah, Adham M., et al.
(Johns Hopkins U School of Medicine)
Abstract
In severe viral pneumonia, including Coronavirus disease 2019 (COVID-19), the viral replication phase is often followed by hyperinflammation ('cytokine storm syndrome'), which can lead to acute respiratory distress syndrome, multi-organ failure, and death. We previously demonstrated that alpha-1 adrenergic receptor (alpha-1-AR) antagonists can prevent cytokine storm syndrome in mice. Here, we conducted retrospective analyses in two cohorts of patients with acute respiratory distress (ARD, n=19,659) and three cohorts with pneumonia (n=423,897). Federated across two ARD cohorts, our main result shows that patients using alpha-1-AR antagonists, as compared to non-users, had a 40% relative risk reduction for ventilation and dying (p=0.014). We replicated these methods on three pneumonia cohorts, all with similar effects on both outcomes. All results were robust to various sensitivity analyses. These results highlight the urgent need for prospective trials testing whether prophylactic use of alpha-1-AR antagonists ameliorates diseases associated with cytokine storm syndrome, such as COVID-19.
Suggested Citation
Koenecke, Allison & Powell, Michael & Xiong, Ruoxuan & Shen, Zhu & Fischer, Nicole & Huq, Sakibul & Khalafallah, Adham M., et al., 2020.
"Alpha-1 Adrenergic Receptor Antagonists to Prevent Acute Respiratory Distress Syndrome and Death from Cytokine Storm Syndrome,"
Research Papers
3893, Stanford University, Graduate School of Business.
Handle:
RePEc:ecl:stabus:3893
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ecl:stabus:3893. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: the person in charge (email available below). General contact details of provider: https://edirc.repec.org/data/gsstaus.html .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.